ConductScience.org, home

Paper21396934

P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.

Chapman JV and 4 others. Exp Cell Res, 2011. Cited by 15 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells. Papers, record 21396934. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21396934

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.
PubMed
Journal
Exp Cell Res
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.51
iCite
Revised in PubMed
2025-05-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chapman JVJacqueline V
2Gouazé-Andersson VValérie
3Karimi RRamin
4Messner MCMaria C
5Cabot MCMyles C

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ATP Binding Cassette Transporter, Subfamily B, Member 1Major topic
CeramidesMajor topic
Drug Resistance, MultipleMajor topic
Drug Resistance, NeoplasmMajor topic
Ovarian NeoplasmsMajor topic
TamoxifenMajor topic
Antineoplastic Agents, Hormonal
Antineoplastic Combined Chemotherapy Protocols
Blotting, Western
Drug Synergism
Female
Glucosyltransferases
Humans
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 GM077391NIGMS NIH HHSUnited StatesR01GM077391PubMed and NIH
GM77391NIGMS NIH HHSUnited StatesR01GM077391PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References72

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115845415Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.Toxicol Appl Pharmacol2005https://conductscience.org/library/papers/15845415PubMed
211106681Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.J Natl Cancer Inst2000https://conductscience.org/library/papers/11106681PubMed
318245173A role for ceramide in driving cancer cell resistance to doxorubicin.FASEB J2008https://conductscience.org/library/papers/18245173PubMed
414662772Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis.J Biol Chem2004https://conductscience.org/library/papers/14662772PubMed
511238696Targeting ceramide metabolism--a strategy for overcoming drug resistance.J Natl Cancer Inst2001https://conductscience.org/library/papers/11238696PubMed
615867385Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.Cancer Res2005https://conductscience.org/library/papers/15867385PubMed
711305904Enzymes of sphingolipid metabolism: from modular to integrative signaling.Biochemistry2001https://conductscience.org/library/papers/11305904PubMed
812558497Killing tumours by ceramide-induced apoptosis: a critique of available drugs.Biochem J2003https://conductscience.org/library/papers/12558497PubMed
99052757Tamoxifen activates cellular phospholipase C and D and elicits protein kinase C translocation.Int J Cancer1997https://conductscience.org/library/papers/9052757PubMed
1012467215P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs.Mol Cancer Ther2002https://conductscience.org/library/papers/12467215PubMed
112148864Glucosyceramide synthase of mouse kidney: further characterization with an improved assay method.Arch Biochem Biophys1990https://conductscience.org/library/papers/2148864PubMed
1210692420
Retroviral transfection of Madin-Darby canine kidney cells with human MDR1 results in a major increase in globotriaosylceramide and 10(5)- to 10(6)-fold increased cell sensitivity to verocytotoxin. Role of p-glycoprotein in glycolipid synthesis.
J Biol Chem2000https://conductscience.org/library/papers/10692420PubMed
1311391861Taxol-induced ceramide generation and apoptosis in human breast cancer cells.Cancer Chemother Pharmacol2001https://conductscience.org/library/papers/11391861PubMed
1410702281Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance.J Biol Chem2000https://conductscience.org/library/papers/10702281PubMed
151483461Metabolic effects of short-chain ceramide and glucosylceramide on sphingolipids and protein kinase C.Eur J Biochem1992https://conductscience.org/library/papers/1483461PubMed
1615868961Quantitative and functional assay of MDR1/P170-mediated MDR in ascites cells of patients with ovarian cancer.Anticancer Res2005https://conductscience.org/library/papers/15868961PubMed
1717828752ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel.J Pharm Sci2008https://conductscience.org/library/papers/17828752PubMed
1815047220Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples.Gynecol Oncol2004https://conductscience.org/library/papers/15047220PubMed
1915141021Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy.Mol Cancer Ther2004https://conductscience.org/library/papers/15141021PubMed
201360704Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.Science1992https://conductscience.org/library/papers/1360704PubMed

See all 72 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
39337312The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism-An Unconventional Ally in Cancer Treatment.Int J Mol Sci2024https://conductscience.org/library/papers/39337312PubMed
36980769Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid Leukemia.Cancers (Basel)2023https://conductscience.org/library/papers/36980769PubMed
36058252Intrinsic adaptations in OXPHOS power output and reduced tumorigenicity characterize doxorubicin resistant ovarian cancer cells.Biochim Biophys Acta Bioenerg2022https://conductscience.org/library/papers/36058252PubMed
30962310Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulation.J Lipid Res2019https://conductscience.org/library/papers/30962310PubMed
30060815Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.Adv Cancer Res2018https://conductscience.org/library/papers/30060815PubMed
27703266LC-MS Based Sphingolipidomic Study on A2780 Human Ovarian Cancer Cell Line and its Taxol-resistant Strain.Sci Rep2016https://conductscience.org/library/papers/27703266PubMed
25964209Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.Biochim Biophys Acta2015https://conductscience.org/library/papers/25964209PubMed
25810474Challenges and Potential for Ovarian Preservation with SERMs.Biol Reprod2015https://conductscience.org/library/papers/25810474PubMed
25769964Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics.Biochim Biophys Acta2015https://conductscience.org/library/papers/25769964PubMed
23510065Gaucher's disease and cancer: a sphingolipid perspective.Crit Rev Oncog2013https://conductscience.org/library/papers/23510065PubMed

Download CSV of cited by

Genes16

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21396934

GET https://conductscience.org/api/papers/v1/21396934/references?page=2